Previous
Previous

Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests

Next
Next

360Dx: Alzheimer’s Biomarker Research Pushing Plasma P-Tau217 to the Fore